The anti-apoptotic genes, such as Bcl-2 and Bcl-XL, increased their expression in tumor-bearing rats as compared to normal rats, whereas tumor-bearing rats treated with 1,3-BPMU had downregulated Bcl-2 and Bcl-XL expressions as compared to tumor-bearing rats. Here, BCL2L1 is linked to neoplasm.